Saturday, February 16, 2019
    Latest

    Leukemia

    Home Leukemia
    Leukemia

    MSKCC Reports on Ibrutinib & Nivolumab Combo in R/R NHL &...

    0
    Leukemia
    Leukemia

    OICR Leukemia Trials to Draw in Major Commercial Sponsor Money

    0
    Leukemia
    Leukemia

    Pfizer Study Evaluates Addition of Glasdegib in AML & High-Risk MDS...

    0
    Leukemia

    PriceWatch: Venetoclax Shows Benefits Across a Range of Hematologic Cancers

    0
    Leukemia

    FDA Approves Treatment for Rare Blood Disease

    0
    Leukemia

    Children’s Hospital LA Researcher Awarded $1.2 Million to Study Leukemia Drug...

    0
    Leukemia

    St. Jude Children’s Hospital Advances Leukemia Research

    0
    Leukemia

    The Leukemia & Lymphoma Society Investing Over $188 Million in Cancer...

    0
    Leukemia

    MD Anderson Phase 2 Study Reveals Combo Chemo & Immunotherapy Effective...

    0
    Leukemia

    Washington Univ. St. Louis Receives $11.5 Million for Leukemia Research

    0
    12Page 1 of 2
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved